Applied DNA Sciences News

8-K/A: Current report (Amendment)

14:50 ET

Applied DNA Sciences | 8-K: Applied DNA Announces 1-For-20 Reverse Stock Split

Apr 22 17:03 ET

Applied DNA Sciences | 8-K: Amendment to Warrant Agreement

Apr 19 16:21 ET

Applied DNA Sciences | 8-K：Poll Results of Special Meeting with the Stockholders

Apr 16 16:16 ET

Applied DNA Sciences | EFFECT: Others

Mar 21 06:06 ET

Applied DNA Sciences | 424B3: Prospectus

Mar 20 17:04 ET

UPLOAD: Others

Mar 18 12:49 ET

CORRESP: CORRESP

Mar 18 12:49 ET

Applied DNA Sciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Mar 15 17:09 ET

Applied DNA Sciences | DEFA14A: Others

Mar 15 12:51 ET

Applied DNA Sciences | DEF 14A: Definitive information statements

Mar 14 16:38 ET

Applied DNA Sciences | S-1: General form for registration of securities under the Securities Act of 1933

Mar 12 12:55 ET

Applied DNA Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 4 17:24 ET

Applied DNA Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bruce Grossman(9.8%)

Feb 12 16:30 ET

Applied DNA Sciences | D: Filing D

Feb 12 16:11 ET

Applied DNA Sciences | 8-K: Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results

Feb 8 16:09 ET

Applied DNA Sciences | 10-Q: Quarterly report

Feb 8 16:06 ET

Applied DNA Sciences | 424B5: Prospectus

Feb 1 16:09 ET

Applied DNA Sciences | 8-K: Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Feb 1 11:52 ET

Applied DNA Sciences | 8-K: Termination of a Material Definitive Agreement

Jan 31 12:00 ET